Sage Journals: Discover world-class research

Abstract

Background

Limited information is available on the effect of systemic lupus erythematosus (SLE) on outcomes, and healthcare resource utilization and expenditures. Such evidence can help improve care for patients with SLE.

Objectives

We examined the associations between SLE and clinical and psychosocial outcomes, healthcare resource utilization, and direct healthcare expenditures.

Methods

We conducted a retrospective US population-based cross-sectional study using the US 2017–2022 Medical Expenditure Panel Survey data. We identified patients with SLE as those who both self-reported SLE diagnosis and either reported SLE-related medication use and/or visited a rheumatologist in the survey year. We matched eight patients without SLE to each patient with SLE on survey year, age, and sex, to create a reference cohort. The outcomes we assessed included clinical outcomes, psychosocial outcomes, healthcare resource utilization, and direct healthcare expenditures. We conducted appropriate multivariable regressions to examine the associations between SLE and each outcome.

Results

Patients with SLE had significantly lower mean physical component summary (PCS) scores than those without SLE by almost five points (p < .0001). Patients with SLE reported higher odds of pain interference with activities (adjusted odds ratio (AOR) = 1.998, 95% confidence interval (CI):1.372–2.909), fair to poor physical health status (AOR = 3.141, 95% CI: 1.993–4.949), cognitive limitations (AOR = 2.665, 95% CI: 1.465–4.849), functional limitations (AOR = 2.594, 95% CI: 1.646–4.089), social limitations (AOR = 2.227, 95% CI: 1.437–3.451), and psychological distress (AOR = 2.023, 95% CI: 1.447–2.827). Likewise, patients with SLE had higher adjusted rates of outpatient visits (adjusted annualized event rate ratio (AAERR) = 2.603, p < .05), office-based visits (AAERR = 1.447, p < .05), and emergency room visits (AAERR = 1.518, p < .05). Regarding healthcare expenditures, those with SLE had significantly higher average annual healthcare expenditures than those without SLE ($18,566 vs $9,366, p < .0001), and the findings were consistent across each healthcare resource component. In the adjusted analyses, average annual healthcare expenditures for individuals with SLE were significantly higher than those without SLE ($13,664 vs $11,781, p < .05).

Conclusion

Poor physical HRQoL, increased cognitive and functional limitations, and psychological distress are common among patients with SLE. Healthcare professionals across different disciplines should address these issues during visits and provide appropriate support and resources for patients with SLE. We also found higher healthcare resource utilization and higher healthcare expenditures among patients with SLE than their non-SLE counterparts.

Keywords

Systemic lupus erythematosus medical expenditure panel survey psychosocial outcomes expenditures healthcare resource utilization

Get full access to this article

View all access options for this article.

References

Kiriakidou

Ching

. Systemic lupus erythematosus. Ann Intern Med 2020; 172: ITC81–ITC96. https://doi.org/10.7326/AITC202006020

McElhone

Abbott

Teh

. A review of health-related quality of life in systemic lupus erythematosus. Lupus 2006; 15(10): 633–643. https://doi.org/10.1177/0961203306071710

Moldovan

Katsaros

Carr

, et al. The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus 2011; 20(12): 1285–1292. https://doi.org/10.1177/0961203311412097

Jolly

. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol 2005; 32(9): 1706–1708.

Liao

Kang

, et al. A cross-sectional study of the association of anxiety and depression with the disease activity of systemic lupus erythematosus. BMC Psychiatry 2022; 22: 591. https://doi.org/10.1186/s12888-022-04236-z

Rayes

Tani

Kwan

, et al. What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Semin Arthritis Rheum 2018; 48: 240–255. https://doi.org/10.1016/j.semarthrit.2018.02.007

Grabich

Farrelly

Ortmann

, et al. Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016-2018. Lupus Science & Medicine 2022; 9: e000640. https://doi.org/10.1136/lupus-2021-000640

Plantinga

Bowling

Pearce

, et al. Limitations in activities of daily living among individuals with systemic lupus erythematosus. Arthritis Care Res 2025; 77(4): 440–450. https://doi.org/10.1002/acr.25446

Clarke

Yazdany

Kabadi

, et al. The economic burden of systemic lupus erythematosus in commercially- and Medicaid-insured populations in the United States. Semin Arthritis Rheum 2020; 50(4): 759–768. https://doi.org/10.1016/j.semarthrit.2020.04.014

10.

Agency for Healthcare Research and Quality (AHRQ) . Meps HC-201: 2017 full year consolidated data file. Available at: https://meps.ahrq.gov/data_stats/download_data/pufs/h201/h201doc.pdf

11.

Agency for Healthcare Research and Quality (AHRQ) . MEPS HC-214: 2019 medical conditions data file. Available at: https://meps.ahrq.gov/data_stats/download_data/pufs/h214/h214doc.pdf

12.

Vyas

Cohen

Eisenhower

. Association between social determinants of health and systemic lupus erythematosus: a nationally representative analysis of 2017-2021 data. Sci Rep 2025; 15(1): 29095. https://doi.org/10.1038/s41598-025-13071-7

13.

Fanouriakis

Kostopoulou

Alunno

, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 2019; 78: 736–745. https://doi.org/10.1136/annrheumdis-2019-215089

14.

Hahn

McMahon

Wilkinson

, et al. American college of rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 2012; 64: 797–808. https://doi.org/10.1002/acr.21664

15.

Normand

Landrum

Guadagnoli

, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 2001; 54(4): 387–398. https://doi.org/10.1016/s0895-4356(00)00321-8

16.

Austin

. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009; 28(25): 3083–3107. https://doi.org/10.1002/sim.3697

17.

Selim

Rothendler

Qian

, et al. The history and applications of the veterans RAND 12-item health survey (VR-12). J Ambul Care Manag 2022; 45(3): 161–170. https://doi.org/10.1097/JAC.0000000000000420

18.

Kroenke

Spitzer

Williams

. The patient health Questionnaire-2: validity of a two-item depressive screener. Med Care 2003; 41: 1284–1292. https://doi.org/10.1097/01.MLR.0000093487.78664.3C

19.

Bureau of Labor Statistics . US Department of Labor. Consumer price index. Available at: https://www.bls.gov/cpi/factsheets/medical-care.htm

20.

Machlin

Dougherty

. Overview of methodology for imputing missing expenditure data in the Medical Expenditure Panel Survey. Methodology Report No. 19. Agency for Healthcare Research & Quality, 2007. https://meps.ahrq.gov/data_files/publications/mr19/mr19.shtml

21.

Dean

French

Mortensen

. Food insecurity, health care utilization, and health care expenditures. Health Serv Res 2020; 55: 883–893. https://doi.org/10.1111/1475-6773.13283

22.

Pedan

. Analysis of count data using the SAS® system. Stat Anal Data Min; 6. https://support.sas.com/resources/papers/proceedings/proceedings/sugi26/p247-26.pdf.

23.

Cassell

DL.

193-31: wait! wait! don’t tell me…you’re using the wrong proc!

https://support.sas.com/resources/papers/proceedings/proceedings/sugi31/193-31.pdf

24.

Gregori

Petrinco

, et al. Regression models for analyzing costs and their determinants in health care: an introductory review. Int J Qual Health Care 2011; 23(3): 331–341. https://doi.org/10.1093/intqhc/mzr010

25.

Manning

Mullahy

. Estimating log models: to transform or not to transform? J Health Econ 2001; 20(4): 461–494. https://doi.org/10.1016/s0167-6296(01)00086-8

26.

Schreiber-Gregory

. Multicollinearity: what is it, why should we care, and how can it be controlled? Available at: https://support.sas.com/resources/papers/proceedings17/1404-2017.pdf

27.

Schmeding

Schmeider

. Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Prac Clin Rheumatol 2013; 27(3): 363–375.

28.

Nishimura

Omori

Katsumata

, et al. Psychological distress in corticosteroid-naïve patients with systemic lupus erythematosus: a prospective cross-sectional study. Lupus 2015; 25(5): 463–471. https://doi.org/10.1177/0961203315615223

29.

Yazdany

Jorge

Barber

, et al. Healthy people with lupus 2030: goals to improve the quality of care and health of all people with lupus in the United States. Arthritis Rheumatol 2023; 75(supp 9), Available at: https://acrabstracts.org/abstract/healthy-people-with-lupus-2030-goals-to-improve-the-quality-of-care-and-health-of-all-people-with-lupus-in-the-united-states/ (Accessed October 5, 2025).

30.

Lin

Murimi-Worstell

Kan

, et al. Health care utilization and costs of systemic lupus erythematosus in the United States: a systematic review. Lupus 2022; 31(7): 773–807. https://doi.org/10.1177/09612033221088209

31.

Garris

Shah

Farrelly

. The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims. Cost Eff Resour Allocation 2015; 13: 9. https://doi.org/10.1186/s12962-015-0034-z

32.

Sarker

Lien

Jetanalin

, et al. Healthcare resource utilization among systemic lupus erythematosus patients in the United States. Value Health 2023; 26(Supp 6): S393. https://doi.org/10.1016/j.jval.2023.03.2197

33.

Jiang

Near

Desta

, et al. Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004-2015. Lupus Sci Med 2021; 8(1): e000503. https://doi.org/10.1136/lupus-2021-000503

34.

Garris

Jhingran

Bass

, et al. Healthcare utilization and costs of systemic lupus erythematosus in a US managed care health plan. J Med Econ 2013; 16: 667–677. https://doi.org/10.3111/13696998.2013.778270

35.

Kan

Song

Johnson

, et al. Healthcare utilization and costs of systemic lupus erythematosus in Medicaid. BioMed Res Int 2013; 2013: 808391. https://doi.org/10.1155/2013/808391

36.

Kuhn

Bonsmann

Anders

, et al. The diagnosis and treatment of systemic lupus erythematosus. Dtsch Arztebl Int 2015; 112: 423–432. https://doi.org/10.3238/arztebl.2015.0423

37.

DeQuattro

Yelin

. Socioeconomic Status, Health Care, and Outcomes in Systemic Lupus Erythematosus. Rheum Dis Clin North Am. 2020 Nov; 46(4): 639–649. https://doi.org/10.1016/j.rdc.2020.07.004

38.